[HTML][HTML] Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - Springer
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - pubmed.ncbi.nlm.nih.gov
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
[HTML][HTML] Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - ncbi.nlm.nih.gov
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - search.proquest.com
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
[HTML][HTML] Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - trialsjournal.biomedcentral.com
Phase 1 drug trials are popular treatment options for patients with advanced disease,
despite the greater levels of uncertainty associated with them. However, their meaning and …
despite the greater levels of uncertainty associated with them. However, their meaning and …
Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences.
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> Phase 1 drug trials are popular treatment
options for patients with advanced disease, despite the greater levels of uncertainty …
options for patients with advanced disease, despite the greater levels of uncertainty …
Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences.
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - europepmc.org
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
Hope and meaning-making in phase-one oncology trials: A systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - Trials, 2022 - orca.cardiff.ac.uk
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
[PDF][PDF] Hope and meaning-making in phase 1 oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences
K Escritt, M Mann, A Nelson, E Harrop - 2022 - trialsjournal.biomedcentral.com
Background: Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …
Hope and meaning-making in phase 1oncology trials: a systematic review and thematic synthesis of qualitative evidence on patient-participant experiences.
M Mann, A Nelson, E Harrop - Trials, 2022 - orca.cardiff.ac.uk
Background Phase 1 drug trials are popular treatment options for patients with advanced
disease, despite the greater levels of uncertainty associated with them. However, their …
disease, despite the greater levels of uncertainty associated with them. However, their …